Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

Reeve J, Maden M, Hill R, et al. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol Assess. 2022;26(32):1-148. doi:10.3310/aafo2475.

Save
Print
October 5, 2022
Reeve J, Maden M, Hill R, et al. Health Technol Assess. 2022;26(32):1-148.
View more articles from the same authors.

Deprescribing is a strategy to reduce potential harms associated with polypharmacy. This scoping review synthesized the evidence about how physicians and patients feel about deprescribing and how deprescribing can be done safely. Shared decision making was identified as an essential component for building trust in the process and for keeping it patient-centered.

Save
Print
Cite
Citation

Reeve J, Maden M, Hill R, et al. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol Assess. 2022;26(32):1-148. doi:10.3310/aafo2475.

Related Resources From the Same Author(s)